Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/262129 
Year of Publication: 
2022
Series/Report no.: 
Research Paper No. 154
Publisher: 
South Centre, Geneva
Abstract: 
In the context of a health emergency like the COVID-19 pandemic, the global availability of and access to vaccines are imperative. This research paper provides an analysis from the perspective of international political economy, of the financing of COVID-19 vaccines and of the market strategies adopted by some of the companies that developed them. It notes that the development of vaccines was supported by substantial public funding from countries that later received preferential access to those vaccines through advance purchases. Despite such public support, the vaccines were not deemed as public goods but remained under the control of their developers.
Subjects: 
Access to Vaccines
Advance Purchases
COVID-19
Global Common Goods
Global Health
Global Public Good
Global South
Health
Intellectual Property
Pandemic
Patent
Public Health
Vaccine Financing
Vaccines
Document Type: 
Research Report
Appears in Collections:

Files in This Item:
File
Size
4.97 MB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.